The title compound, 2-[(4-chlorophenyl)(1H-indol-3-yl)methyl]-1H-indole was synthesized in good yield by condensation reaction between commercially available indole and 4-chlorobenzaldehyde under constant stirring in glacial acetic acid as a catalyst and solvent. The product obtained was characterized by spectroscopic techniques and finally the structure was confirmed by X-ray diffraction studies. The compound crystallizes in the triclinic crystal system with the space group P-1 with unit cell parameters a = 7.4955(4) Å, b = 12.0832(7) Å, c = 13.7889(8) Å, α = 106.727(2)o, β = 103.691(2)o,γ = 96.829(2)o and Z=2. The crystal structure features a strong N-- H…O hydrogen bond with different packing motifs. In the crystal string N—H...π, C—H…π and C—H...Cl interactions occur, forming a three dimensional network.
Select your language of interest to view the total content in your interested language
Der Pharma Chemica received 15261 citations as per Google Scholar report